Program Details

General Details

Thursday, December 2, 2021
6PM-8PM EST

 

Location

Please use the following link to join the debate: https://liverfoundation-org.zoom.us/j/91463452463

 

Topics

 

 

DEBATE #1:

Liver transplant should be offered for patients with extensive isolated colorectal liver metastases.

PRO: University of Maryland

CON: Johns Hopkins University School of Medicine 

DEBATE #2:

Hepatologists should serve a primary role in managing alcohol use disorder in patients with advanced liver disease.

PRO: Medstar Georgetown University Hospital

CON: National Institutes of Health

Teams

 

  1. University of Maryland 
  2. Johns Hopkins University School of Medicine
  3. Medstar Georgetown University Hospital
  4. National Institutes of Health (NIH)

Participants

Event Moderator

Rohit Satoskar, MD

Rohit Satoskar, MD, is the Director of Medical Services for the MedStar Georgetown Transplant Institute. He is also medical director of Liver Transplantation and Associate professor in the Department of Medicine at the MedStar Georgetown Transplant Institute. An expert in hepatology and liver transplantation, Dr. Satoskar is board-certified in Internal Medicine, Gastroenterology and Transplant Hepatology. In addition to Dr. Satoskar’s role as a clinician, teacher and researcher, he is actively involved in public policy efforts to benefit patients with liver disease. He serves in leadership positions with professional societies such as the American Association for the Study of Liver Diseases and the American Liver Foundation and is a founding board member of the Global Liver Institute dedicated to collaboration and innovation in dealing with liver disease. 

Judges

Atoosa Rabiee, MD

Originally from Iran, Dr. Rabiee is a graduate of Tehran University of Medical Sciences. In the USA, she completed two year of research fellowship on T32 grant prior to applying for residency. She then finished her internal medicine residency at Johns Hopkins Bayview Medical Center, followed by gastroenterology fellowship at University of Miami Jackson Memorial hospital. She graduated from transplant hepatology fellowship at Johns Hopkins hospital in 2017 and joined the VA in Washington DC right after and now serves as the clinical director of hepatology. Her main interests include portal hypertension and hepatocellular carcinoma. 

Theo Heller, MD

Dr. Heller is the chief of the Translational Hepatology Section at the NIH. His research focuses on the progression and regression of liver diseases. He utilizes rare diseases as a means of understanding the pathogenesis of portal hypertension with the ultimate goal of utilizing this understanding to develop therapeutics. 

Ruhail Kohli, MD

Dr. Ruhail Kohli, M.B. B.Ch. B.A.O is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at the Johns Hopkins University. He received his medical degree from the Royal College of Surgeons in Ireland and subsequently completed his Internal Medicine training at the Cleveland Clinic. He completed his Gastroenterology and Transplant Hepatology fellowships at the University of Colorado in Denver, Colorado.  Dr. Kohli is a clinician-educator and serves as the Associate Program Director of the Gastroenterology, Transplant Hepatology and Advanced Hepatology Fellowships at Johns Hopkins University .   

University of Maryland

Mentor

Sasan Sakiani, MD

Sasan Sakiani, MD is a Transplant Hepatology Specialist in Baltimore, MD and has over 21 years of experience in the medical field. He graduated from Ross University / School of Medicine & Veterinary Medicine medical school in 2000. He is affiliated with University Of Maryland Medical Center.

Fellow

Muhammad Hammami, MD

I was born in Oakland, California, but I was raised and grew up in the Middle East. I completed medical school in Jordan, where I attended Jordan University of Science and Technology. Upon moving back to the United States, I settled in Florida and completed my Internal Medicine residency at Florida Atlantic University, where I served as a chief medical resident, and my interest in liver disease came to fruition. I completed an advanced hepatology fellowship at John Hopkins University, and now I am a second gastroenterology fellow at the University of Maryland Medical Center. My research and clinical interests are in non-alcoholic fatty liver disease and cirrhotic cardiomyopathy. 

Fellow

Ameer Abutaleb, MD

Ameer received his Medical Degree from the University of Maryland School of Medicine, completed his fellowship in Gastroenterology and Hepatology in 2021, and is currently a Transplant Hepatology fellow. He has engaged in research with the Division of Gastroenterology and Hepatology for several years. His work has included linkage to care in marginalized populations with viral hepatitis and app development for large scale HBV vaccination and HCV treatment programs. His current research interests include viral hepatitis and HIV-related liver disease. 

Johns Hopkins University School of Medicine

 Mentor

Ruhail Kohli, MD

Dr. Ruhail Kohli, M.B. B.Ch. B.A.O is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at the Johns Hopkins University. He received his medical degree from the Royal College of Surgeons in Ireland and subsequently completed his Internal Medicine training at the Cleveland Clinic. He completed his Gastroenterology and Transplant Hepatology fellowships at the University of Colorado in Denver, Colorado.  Dr. Kohli is a clinician-educator and serves as the Associate Program Director of the Gastroenterology, Transplant Hepatology and Advanced Hepatology Fellowships at Johns Hopkins University.

Fellow

Brian Ting, MD

Why Johns Hopkins: Johns Hopkins has been my home for three years on the Osler Medical Service before gastroenterology fellowship and this hospital has captivated me with its dedication to patient care, spirit of innovation, and wealth of resourcefulness of the faculty at large. The gastroenterology and hepatology training program has come from the same tradition and I am glad to be part of this program both for my peers and as I walk on the shoulder of giants.
Hobbies: The waterfront of Baltimore is a sight that I have never gotten tired of. It is an amazing place to exercise, hang out with friends and colleagues, and read. There are numerous bodies of water around that are available for boating, fishing, and simply walking on the trails. On the more metropolitan side aside from the inner harbor, DC offers a great scene for city living and is a great day trip as well.
Interests in GI: Hepatology

Fellow

Aly Strauss, MD 

Aly Strauss is a transplant hepatology fellow at Johns Hopkins University. She is a PhD candidate in clinical investigation at the Johns Hopkins University School of Public Health where her research focus is disparities in liver transplant.  

Aly Strauss MD, MIE 

Transplant Hepatology Fellow, Division of Gastroenterology & Hepatology, JHU SOM 

PhD Candidate, JHU Bloomberg SPH 

Medstar Georgetown University Hospital

Mentor

Kathleen Nilles, MD

Dr. Kathleen M. Nilles is triple board-certified in Internal Medicine, Gastroenterology / Hepatology, and Transplant Hepatology. She attended the University of Pittsburgh School of Medicine followed by internal medicine residency at Emory University, and Gastroenterology and Hepatology fellowship at the University of Colorado. She then completed an advanced fellowship in transplant hepatology at Northwestern University before joining MedStar Georgetown University Hospital.

Fellow

Veronica Nguyen, MD

Dr. Nguyen hails from the Pacific Northwest, with roots in Seattle and an Alumna of the University of Washington. After college, she spent time in the Lingappa Lab at UW studying HIV capsid assembly before attending medical school at Albany Medical College. Subsequently she completed Internal Medicine residency at Georgetown University and Gastroenterology fellowship at the University of Arizona where she served as Chief Fellow. She returns to Georgetown for an advance year of clinical training in Transplant Hepatology. Dr. Nguyen’s interests include hepatocellular carcinoma, alcohol-related liver diseases, acute on chronic liver failure, infections in cirrhosis, patient outcomes in liver diseases and medical education. She is an active member of the American Association of Liver Diseases (AASLD) and American College of Gastroenterology and is a social media correspondent for the Liver Meeting. 

Fellow

Erinda Stefi, DO

Dr. Erinda Stefi is currently a transplant hepatology fellow at Medstar Georgetown University Hospital. Prior to this, she completed Internal Medicine Residency and Gastroenterology Fellowship at Wake Forest Baptist Medical Center (2015-2021).  

National Institutes of Health

Mentor

Theo Heller, MD

Dr. Heller is the chief of the Translational Hepatology Section at the NIH. His research focuses on the progression and regression of liver diseases. He utilizes rare diseases as a means of understanding the pathogenesis of portal hypertension with the ultimate goal of utilizing this understanding to develop therapeutics. 

Fellow

David Yardeni, MD

2nd year Clinical Fellow, Liver Disease Branch, NIDDK, NIH 

Completed Medial School at Ben-Gurion University of the Negev, Beer Sheva, Israel in 2011. Completed Internal Medicine residency at Soroka University Medical Center, Beer Sheva Israel, in 2015. 

Completed Gastroenterology and Liver disease Fellowship in Soroka University Medical Center, Beer Sheva Israel, in 2018. 

Fellow

Gracia Maria Viana, MD

2nd year Clinical Fellow, Liver Disease Branch, NIDDK, NIH 

Completed Medial School at  Universidad Jose Matias Delgado, El Salvador in 2014. Completed Internal Medicine residency at Yale New Haven Health, Bridgeport Hospital,  Connecticut in 2020.